SEC Form 4 · accession 0001179110-15-006614
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Craig A Wheeler
Officer — President · Director
Period of report
Apr 23, 2015
Accepted (ET)
Apr 27, 2015 · 2:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 23, 2015 | M | 41,667 | $16.18 | A | 300,296 | D | |
| Common Stock | Apr 23, 2015 | S | 41,667 | $20.00 | D | 258,629 | D | |
| Common Stock | Apr 23, 2015 | S | 10,000 | $20.00 | D | 196,308 | I | Craig Wheeler Revocable Trust |
| Common Stock | holding | — | — | — | 150,000 | I | Craig A. Wheeler 2014 Irrevocable Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $16.18 | Apr 23, 2015 | M | 41,667 | A | Aug 22, 2010 | Aug 22, 2016 | Common Stock | 41,667 | 333,333 | D |
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 14, 2013.
- F2This sale was effected pursuant to a Rule 10b5-1 Craig Wheeler Revocable Trust trading plan adopted by the reporting person on June 14, 2013.